References
- Burls A, Jordan R, Barton P et al. Vaccinating healthcare workers against influenza to protect the vulnerable – is it a good use of healthcare resources? A systematic review of the evidence and an economic evaluation. Vaccine24(19), 4212–4221 (2006).
- van Delden JJ, Ashcroft R, Dawson A, Marckmann G, Upshur R, Verweij MF. The ethics of mandatory vaccination against influenza for health care workers. Vaccine26(44), 5562–5566 (2008).
- Lackenby A, Hungnes O, Dudman SG et al. Emergence of resistance to oseltamivir among influenza A(H1N1) viruses in Europe. Euro Surveill.13(5), 8026 (2008).
- Rumke HC, Bayas JM, de Juanes JR et al. Safety and reactogenicity profile of an adjuvanted H5N1 pandemic candidate vaccine in adults within a Phase III safety trial. Vaccine26(19), 2378–2388 (2008).
- Simonson L, Taylor RJ, Viboud C et al. Mortality benefits of influenza vaccination in elderly people: an ongoing controversy. Lancet Infect. Dis.7(10), 658–666 (2008).
- Jansen AG, Sanders EA, Nichol KL et al. Decline in influenza-associated mortality among Dutch elderly following the introduction of a nationwide vaccination program. Vaccine26(44), 5567–5574 (2008).
- Lowen AC, Mubareka S, Tumpey TM et al. The guinea pig as a transmission model for human influenza viruses. Proc. Natl Acad. Sci. USA103(26), 9988–9992 (2006).
- McAuley JL, Hornung F, Boyd KL et al. Expression of the 1918 influenza A virus PB1-F2 enhances the pathogenesis of viral and secondary bacterial pneumonia. Cell Host Microbe2(4), 240–249 (2007).
- Russell CA, Jones TC, Barr IG et al. The global circulation of seasonal influenza A (H3N2) viruses. Science320(5874), 340–346 (2008).